Ftse Mib
33.968,78
1,01%
DAX
18.175,21
1,01%
S&P 500
5.166,70
0,76%
NASDAQ
16.301,01
0,90%
Bitcoin
62.958,68
-1,63%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NexGel Inc (NXGL) NexGel Inc (NXGL) Notizie

NexGel Inc

NXGL
2,1589
-0,0611 (-2,75%)
Ultimo aggiornamento: 20:50:22
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/4/202414:00GLOBENEXGEL to Present at the Planet MicroCap Showcase: VEGAS..
01/4/202413:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
27/3/202414:00GLOBENEXGEL Reschedules Fourth Quarter and Full Year 2023..
21/3/202414:00GLOBENEXGEL to Report Fourth Quarter and Full Year 2023 Financial..
05/3/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202414:30GLOBENEXGEL to Present at the iAccess Alpha Best Ideas Spring..
21/2/202422:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/2/202422:15EDGAR2Form 8-K - Current report
21/2/202422:05GLOBENEXGEL Announces $975,000 Registered Direct Offering Led by..
31/1/202415:05EDGAR2Form 8-K - Current report
18/1/202415:00GLOBENEXGEL to Present at The Microcap Conference, January 30th..
16/1/202422:30EDGAR2Form 8-K - Current report
09/1/202414:30GLOBENEXGEL Subsidiary, CG Converting and Packaging, Begins..
29/12/202322:30EDGAR2Form 8-K - Current report
26/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:52EDGAR2Form 8-K - Current report
11/12/202314:15EDGAR2Form 8-K - Current report
11/12/202314:00GLOBENEXGEL Announces Partnership with STADA to Distribute and..
05/12/202314:10EDGAR2Form 8-K - Current report
05/12/202314:00GLOBENEXGEL Acquires Kenkoderm Psoriasis Skincare Line
13/11/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:10EDGAR2Form 8-K - Current report
13/11/202322:05GLOBENEXGEL Reports Record Third Quarter 2023 Revenue of $1.2..
02/11/202314:00GLOBENEXGEL to Report Third Quarter 2023 Financial Results on..
30/10/202313:30EDGAR2Form 8-K - Current report
30/10/202313:00GLOBENEXGEL Secures Supply Agreement with AbbVie
26/9/202315:49GLOBENEXGEL to Participate in the LD Micro Main Event XVI on..
15/9/202300:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202300:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202323:29EDGAR2Form 8-K - Current report
14/8/202322:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:05GLOBENEXGEL Reports Second Quarter 2023 Record Revenue of $1.17..
02/8/202315:00GLOBENEXGEL to Report Second Quarter 2023 Financial Results on..
19/7/202315:10GLOBENEXGEL Partners with Enigma Health to Distribute its Leading..
15/6/202315:00GLOBENEXGEL to Participate in Maxim Group’s Virtual Healthcare..
24/5/202315:00GLOBENEXGEL to Participate in the LD Micro Invitational XIII on..
15/5/202322:05GLOBENEXGEL Reports First Quarter 2023 Financial Results
09/5/202315:15GLOBENEXGEL to Report First Quarter 2023 Financial Results on May..
Apertura: 2,13 Min: 2,13 Max: 2,22
Chiusura: 2,22

La tua Cronologia

NASDAQ
NXGL
NexGel
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network